1.05
0.02 (1.94%)
0.02 (1.94%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.98% | 1.03 | 1.00 | 1.0888 | 1.03 | 1.02 | 00:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.89 | 1.50 | 0.61 | 40.67% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,346 | 315,091 | $ 1.04 | $ 327,940 | 939,032 | 0.81 - 4.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:32:23 | 2 | $ 1.05 | USD |
Arbutus Biopharma Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 72.21M | 70.11M | $ -57.06M | -2.89 | - | 64.18M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 6.00 | 8.50% |
Arbutus Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABUS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.09 | 1.25 | 0.88 | 0.9908554 | 692,700 | -0.06 | -5.5% |
| 1 Month | 2.41 | 2.58 | 0.88 | 1.30 | 1,066,858 | -1.38 | -57.26% |
| 3 Months | 3.06 | 4.22 | 0.88 | 2.21 | 800,831 | -2.03 | -66.34% |
| 6 Months | 0.9284 | 4.22 | 0.81 | 2.10 | 723,570 | 0.1016 | 10.94% |
| 1 Year | 4.39 | 4.39 | 0.81 | 2.08 | 550,206 | -3.36 | -76.54% |
| 3 Years | 3.25 | 12.60 | 0.81 | 4.15 | 367,754 | -2.22 | -68.31% |
| 5 Years | 17.66 | 19.61 | 0.81 | 5.44 | 346,616 | -16.63 | -94.17% |
Arbutus Biopharma Description
| Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology. |
